{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:33:28Z","timestamp":1759624408985,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":4967,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.exphem.2008.05.009","type":"journal-article","created":{"date-parts":[[2008,8,10]],"date-time":"2008-08-10T04:13:36Z","timestamp":1218341616000},"page":"1524-1534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Tumorigenic potential and disease manifestations of malignant B-cell variants differing in their fibronectin adhesiveness"],"prefix":"10.1016","volume":"36","author":[{"given":"Liat","family":"Nadav","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vyacheslav","family":"Kalchenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meir Max","family":"Barak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Naparstek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Geiger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben-Zion","family":"Katz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2008.05.009_bib1","doi-asserted-by":"crossref","first-page":"7837","DOI":"10.1158\/0008-5472.CAN-06-0863","article-title":"Switching on chromosomal translocations","volume":"66","author":"Ramiro","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2008.05.009_bib2","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1182\/blood-2007-02-069625","article-title":"Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma","volume":"110","author":"Gonzalez","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.05.009_bib3","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/01.cco.0000239882.23839.e5","article-title":"Pathogenesis of AIDS lymphoma: role of oncogenic viruses and B cell activation-associated molecular lesions","volume":"18","author":"Epeldegui","year":"2006","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.exphem.2008.05.009_bib4","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","article-title":"Epstein-Barr virus: 40 years on","volume":"4","author":"Young","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2008.05.009_bib5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrc1589","article-title":"Mechanisms of B-cell lymphoma pathogenesis","volume":"5","author":"Kuppers","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2008.05.009_bib6","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1080\/10428190412331272703","article-title":"Microenvironmental interactions and survival of CLL","volume":"45","author":"Munk Pedersen","year":"2004","journal-title":"B-cells. Leuk Lymphoma"},{"key":"10.1016\/j.exphem.2008.05.009_bib7","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.ejca.2005.12.025","article-title":"The role of the bone microenvironment in the pathophysiology and therapeutic management of multiple myeloma: interplay of growth factors, their receptors and stromal interactions","volume":"42","author":"Mitsiades","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.exphem.2008.05.009_bib8","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1196\/annals.1322.047","article-title":"Targeting multiple myeloma cells and their bone marrow microenvironment","volume":"1028","author":"Pagnucco","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.exphem.2008.05.009_bib9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1158\/0008-5472.CAN-05-1195","article-title":"Bortezomib mediates antiangiogenesis in multiple myeloma via direct and indirect effects on endothelial cells","volume":"66","author":"Roccaro","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2008.05.009_bib10","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1023\/A:1015364104672","article-title":"Death associated protein kinase: from regulation of apoptosis to tumor suppressive functions and B cell malignancies","volume":"7","author":"Ng","year":"2002","journal-title":"Apoptosis"},{"key":"10.1016\/j.exphem.2008.05.009_bib11","first-page":"836","article-title":"Alpha(v)beta(3) integrin engagement enhances cell invasiveness in human multiple myeloma","volume":"87","author":"Ria","year":"2002","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2008.05.009_bib12","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1046\/j.1365-2249.2002.01787.x","article-title":"Adhesion to fibronectin via alpha4 integrin (CD49d) protects B cells from apoptosis induced by serum deprivation but not via IgM or Fas\/Apo-1 receptors","volume":"127","author":"Garcia-Gila","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.exphem.2008.05.009_bib13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1023\/A:1013156407224","article-title":"Mechanisms associated with cell adhesion mediated drug resistance (CAM-DR) in hematopoietic malignancies","volume":"20","author":"Hazlehurst","year":"2001","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.exphem.2008.05.009_bib14","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/25292","article-title":"Genetic instabilities in human cancers","volume":"396","author":"Lengauer","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2008.05.009_bib15","first-page":"503","article-title":"Prognostic significance of clonal diversity of immunoglobulin gene rearrangements in patients with diffuse large B-cell lymphoma","volume":"13","author":"Yang","year":"2005","journal-title":"Oncol Rep"},{"key":"10.1016\/j.exphem.2008.05.009_bib16","doi-asserted-by":"crossref","first-page":"8608","DOI":"10.1158\/0008-5472.CAN-06-1301","article-title":"The generation and regulation of functional diversity of malignant plasma cells","volume":"66","author":"Nadav","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2008.05.009_bib17","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1182\/blood-2002-01-0169","article-title":"V(H) gene analysis of splenic marginal zone lymphomas reveals diversity in mutational status and initiation of somatic mutation in vivo","volume":"100","author":"Zhu","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.05.009_bib18","doi-asserted-by":"crossref","DOI":"10.1117\/1.2364903","article-title":"Use of lipophilic near-infrared dye in whole-body optical imaging of hematopoietic cell homing","volume":"11","author":"Kalchenko","year":"2006","journal-title":"J Biomed Opt"},{"key":"10.1016\/j.exphem.2008.05.009_bib19","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1182\/blood.V93.5.1658","article-title":"Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines","volume":"93","author":"Damiano","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.05.009_bib20","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1182\/blood-2006-03-007294","article-title":"MMP-9 in B-cell chronic lymphocytic leukemia is up-regulated by alpha4beta1 integrin or CXCR4 engagement via distinct signaling pathways, localizes to podosomes, and is involved in cell invasion and migration","volume":"108","author":"Redondo-Munoz","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.05.009_bib21","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1189\/jlb.71.3.495","article-title":"Engagement of alpha4beta1 integrin by fibronectin induces in vitro resistance of B chronic lymphocytic leukemia cells to fludarabine","volume":"71","author":"de la Fuente","year":"2002","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.exphem.2008.05.009_bib22","first-page":"1392","article-title":"Disseminated growth of a human multiple myeloma cell line in mice with severe combined immunodeficiency disease","volume":"53","author":"Huang","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2008.05.009_bib23","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.leu.2404621","article-title":"Bone marrow mesenchymal stem\u00a0cells are abnormal in multiple myeloma","volume":"21","author":"Corre","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2008.05.009_bib24","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.4049\/jimmunol.180.3.1545","article-title":"Bone marrow stroma confers resistance to Apo2 ligand\/TRAIL in multiple myeloma in part by regulating c-FLIP","volume":"180","author":"Perez","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2008.05.009_bib25","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.yexcr.2007.10.021","article-title":"Interactions of myeloma cells with osteoclasts promote tumour expansion and bone degradation through activation of a complex signalling network and upregulation of cathepsin K, matrix metalloproteinases (MMPs) and urokinase plasminogen activator (uPA)","volume":"314","author":"Hecht","year":"2008","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.exphem.2008.05.009_bib26","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10585-007-9108-4","article-title":"Extravasation and homing mechanisms in multiple myeloma","volume":"25","author":"Vande Broek","year":"2008","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.exphem.2008.05.009_bib27","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1054\/bjoc.1999.1024","article-title":"Selective initial in vivo homing pattern of 5T2 multiple myeloma cells in the C57BL\/KalwRij mouse","volume":"82","author":"Vanderkerken","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.exphem.2008.05.009_bib28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/10428199809059252","article-title":"Biologic and therapeutic determinants of bone mineral density in multiple myeloma","volume":"32","author":"Dhodapkar","year":"1998","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.exphem.2008.05.009_bib29","first-page":"567","article-title":"Sequential analysis of biochemical markers of bone resorption and bone densitometry in multiple myeloma","volume":"89","author":"Abildgaard","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2008.05.009_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0889-8588(05)70413-5","article-title":"Interaction of tumor and host cells with adhesion and extracellular matrix molecules in the development of multiple myeloma","volume":"11","author":"Teoh","year":"1997","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.exphem.2008.05.009_bib31","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1080\/10428190600649521","article-title":"In-vitro functional phenotypes of plasma cell lines from patients with multiple myeloma","volume":"47","author":"Silvestris","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.exphem.2008.05.009_bib32","first-page":"6504","article-title":"Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis","volume":"54","author":"Weinstat-Saslow","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2008.05.009_bib33","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/BF02631431","article-title":"Growth advantage (\u201cclonal dominance\u201d) of metastatically competent tumor cell variants expressed under selective two- or three-dimensional tissue culture conditions","volume":"29A","author":"Rak","year":"1993","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"10.1016\/j.exphem.2008.05.009_bib34","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1182\/blood-2004-01-0236","article-title":"Anti-alpha4 integrin antibody suppresses the development of multiple myeloma and associated osteoclastic osteolysis","volume":"104","author":"Mori","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.05.009_bib35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2174\/1568009023334033","article-title":"Integrins as novel drug targets for overcoming innate drug resistance","volume":"2","author":"Damiano","year":"2002","journal-title":"Curr Cancer Drug Targets"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X08002312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X08002312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:26:59Z","timestamp":1759566419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X08002312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0301472X08002312"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2008.05.009","relation":{},"ISSN":["0301-472X"],"issn-type":[{"type":"print","value":"0301-472X"}],"subject":[],"published":{"date-parts":[[2008,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumorigenic potential and disease manifestations of malignant B-cell variants differing in their fibronectin adhesiveness","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2008.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 ISEH - Society\u00a0for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}